Sleeping Sickness Symptoms, Treatments & Causes
Table of Contents
Sleeping sickness, also known as African trypanosomiasis or human African trypanosomiasis (HAT), is a vector-borne parasitic disease that affects humans and animals in sub-Saharan Africa. This life-threatening infection is caused by tiny parasites called trypanosomes, which are transmitted to humans through the bites of infected tsetse flies. If left untreated, sleeping sickness can lead to swelling of the brain and ultimately result in death.
Overview
Sleeping sickness is a neglected tropical disease that primarily affects rural communities in sub-Saharan Africa. It is caused by two subspecies of the protozoan parasite Trypanosoma brucei: T. b. gambiense and T. b. rhodesiense. The disease is characterized by two stages: the hemolymphatic stage and the neurological stage, which involves the central nervous system.
Causes
Sleeping sickness is caused by the protozoan parasites Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense. These parasites belong to the genus Trypanosoma and are transmitted to humans through the bites of infected tsetse flies. The two subspecies of the parasite cause different forms of the disease, with T. b. gambiense accounting for over 98% of reported cases.
Transmission
The transmission of sleeping sickness occurs through the bites of infected tsetse flies, which are found in sub-Saharan Africa. When a tsetse fly bites an infected human or animal, it ingests the parasites, which then multiply in the fly’s midgut. The parasites then migrate to the fly’s salivary glands, where they can be transmitted to another host during a subsequent blood meal. Tsetse flies can acquire the infection from various animal reservoirs, including cattle, wild animals, and humans.
Symptoms
The symptoms of sleeping sickness occur in two stages: the hemolymphatic stage and the neurological stage. During the hemolymphatic stage, which occurs 1-3 weeks after the initial infection, symptoms may include fever, headache, joint pain, and swollen lymph nodes. As the disease progresses to the neurological stage, patients may experience confusion, poor coordination, sensory disturbances, and disturbances in the sleep cycle, giving the disease its name. If left untreated, sleeping sickness can lead to coma and death.
Hemolymphatic Stage Symptoms
- Fever
- Headache
- Joint pain
- Itching
- Swollen lymph nodes
Neurological Stage Symptoms
- Confusion
- Poor coordination
- Sensory disturbances
- Disturbances in the sleep cycle
- Personality changes
- Progressive mental deterioration
Diagnosis
The diagnosis of sleeping sickness involves a combination of clinical examination and laboratory tests. In endemic areas, a high index of suspicion is necessary, especially in individuals presenting with compatible symptoms. Diagnosis typically involves microscopic examination of blood, lymph node aspirates, or cerebrospinal fluid to detect the presence of trypanosomes. Serological tests, such as the card agglutination test for trypanosomiasis (CATT), can also be used for screening purposes. In the neurological stage, a lumbar puncture is performed to examine the cerebrospinal fluid for the presence of parasites and an elevated white blood cell count.
Treatment
The treatment of sleeping sickness depends on the stage of the disease and the subspecies of the parasite involved. In the hemolymphatic stage, the drugs pentamidine and suramin are used to treat T. b. gambiense and T. b. rhodesiense infections, respectively. In the neurological stage, the drug melarsoprol is used to treat both subspecies, although it is associated with significant toxicity. Eflornithine, often in combination with nifurtimox, is an alternative treatment for the neurological stage of T. b. gambiense infection. Supportive care and management of complications are also crucial aspects of treatment.
Prevention
Prevention of sleeping sickness relies on vector control measures and reducing human-tsetse fly contact. Insecticide-treated targets, traps, and screens can be used to control tsetse fly populations. Personal protection measures, such as wearing protective clothing and using insect repellents, can help reduce the risk of tsetse fly bites. Community-based surveillance and active case detection are important for early diagnosis and treatment, which can prevent the progression of the disease and reduce transmission. Efforts to eliminate the animal reservoir, particularly in the case of T. b. rhodesiense, are also crucial for controlling the disease.
Sleeping sickness remains a significant public health challenge in sub-Saharan Africa, with devastating consequences for affected individuals and communities. Ongoing research and development efforts focus on improving diagnostics, treatment options, and vector control strategies to combat this neglected tropical disease. International collaboration and support from global health organizations are essential in the fight against sleeping sickness and other vector-borne diseases affecting vulnerable populations.
Sources:
- World Health Organization. (2020). Human African trypanosomiasis (sleeping sickness).
- Kennedy, P. G. E. (2019). Update on human African trypanosomiasis (sleeping sickness). Journal of Neurology, 266(9), 2334-2337.
- Büscher, P., Cecchi, G., Jamonneau, V., & Priotto, G. (2017). Human African trypanosomiasis. The Lancet, 390(10110), 2397-2409.
